| Serial Number | 97899029 |
| Word Mark | ACCEL |
| Filing Date | Thursday, April 20, 2023 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Thursday, February 22, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Drug discovery services; pharmaceutical research and development services |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, May 17, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Totus Medicines Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Emeryville, CA 94608 |
| Event Date | Event Description |
| Thursday, February 22, 2024 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Thursday, February 22, 2024 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Wednesday, November 8, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, November 8, 2023 | NON-FINAL ACTION E-MAILED |
| Wednesday, November 8, 2023 | NON-FINAL ACTION WRITTEN |
| Tuesday, November 7, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, May 17, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, April 24, 2023 | NEW APPLICATION ENTERED |